FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monder, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monder, C.

The FASEB Journal, Vol 5, 3047-3054, Copyright © 1991 by The Federation of American Societies for Experimental Biology


REVIEWS

Corticosteroids, receptors, and the organ-specific functions of 11 beta- hydroxysteroid dehydrogenase

C Monder
Population Council, Center for Biomedical Research, New York, New York 10021.

Reversible oxidation of the biologically active corticosteroids to the inactive 11-dehydrocorticosteroids is catalyzed by 11 beta- hydroxysteroid dehydrogenase (11 beta HSD). The properties of the enzyme based on clinical observations of individuals with defective 11 beta HSD expression, and laboratory studies of the properties and behavior of the enzyme, are consistent with separate 11 beta- dehydrogenase and 11-oxoreductase species. However, recombinant enzyme expressed in mammalian cells retain both activities, leading to the conclusion that 11 beta HSD is a unique, reversible enzyme. 11 beta HSD is present in most tissues, but its specific functions in most tissues are unknown. How the enzyme may mediate corticosteroid-receptor interaction is illustrated by studies using kidney, testis, and brain. In kidney, 11 beta HSD prevents glucocorticoids from competing inappropriately with aldosterone for mineralocorticoid receptor (MR). Lack of enzyme in humans due to natural causes or inhibition by pharmacological agents results in maximum activation of MR by glucocorticoids, leading to the clinical symptoms of apparent mineralocorticoid excess. Leydig cells of the testes synthesize testosterone, a process that is suppressed by events initiated by the binding of corticosteroid to glucocorticoid receptors (GR). Depletion of active steroid mediated by 11 beta HSD may initiate testosterone production at puberty and affect testosterone production during adult life, as for example during periods of stress. The heterogeneous distribution of MR and GR in the brain reflects the specific regional effects of glucocorticoids and mineralocorticoids on neural function. Colocalization of 11 beta HSD and corticosteroid receptors in brain may be important in controlling the specificity of corticosteroid interaction with GR and MR. The patterns of 11 beta HSD-steroid- receptor interaction illustrated with these three tissues may provide models applicable to other tissues in which corticosteroid receptors and 11 beta HSD coexist.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. G. Smith, L. Betancourt, and Y. Sun
Molecular Endocrinology and Physiology of the Aging Central Nervous System
Endocr. Rev., April 1, 2005; 26(2): 203 - 250.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L.M. Thurston, D.P. Norgate, K.C. Jonas, L. Gregory, P.J. Wood, B.A. Cooke, and A.E. Michael
Ovarian modulators of type 1 11{beta}-hydroxysteroid dehydrogenase (11{beta}HSD) activity and intra-follicular cortisol:cortisone ratios correlate with the clinical outcome of IVF
Hum. Reprod., August 1, 2003; 18(8): 1603 - 1612.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. J. Pepe, M. G. Burch, and E. D. Albrecht
Localization and Developmental Regulation of 11{beta}-Hydroxysteroid Dehydrogenase-1 and -2 in the Baboon Syncytiotrophoblast
Endocrinology, January 1, 2001; 142(1): 68 - 80.
[Abstract] [Full Text] [PDF]


Home page
The Journal of the Royal Society for the Promotion of HealthHome page
A. Olukoga and D. Donaldson
Liquorice and its health implications
The Journal of the Royal Society for the Promotion of Health, June 1, 2000; 120(2): 83 - 89.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Odermatt, P. Arnold, A. Stauffer, B. M. Frey, and F. J. Frey
The N-terminal Anchor Sequences of 11beta -Hydroxysteroid Dehydrogenases Determine Their Orientation in the Endoplasmic Reticulum Membrane
J. Biol. Chem., October 1, 1999; 274(40): 28762 - 28770.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
A. ANGELI, R. G. MASERA, M. L. SARTORI, N. FORTUNATI, S. RACCA, A. DOVIO, A. STAURENGHI, and R. FRAIRIA
Modulation by Cytokines of Glucocorticoid Action
Ann. N.Y. Acad. Sci., June 22, 1999; 876(1): 210 - 220.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls
Brain Corticosteroid Receptor Balance in Health and Disease
Endocr. Rev., June 1, 1998; 19(3): 269 - 301.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
T. M. Penning
Molecular Endocrinology of Hydroxysteroid Dehydrogenases
Endocr. Rev., June 1, 1997; 18(3): 281 - 305.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Naray-Fejes-Toth and G. Fejes-Toth
Subcellular Localization of the Type 211beta -Hydroxysteroid Dehydrogenase. A GREEN FLUORESCENT PROTEIN STUDY
J. Biol. Chem., June 28, 1996; 271(26): 15436 - 15442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The Federation of American Societies for Experimental Biology.